FAM175B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.745400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.808800E-01
Normal-vs-Stage2
4.844600E-01
Normal-vs-Stage3
6.874000E-02
Normal-vs-Stage4
7.232800E-01
Stage1-vs-Stage2
9.439400E-01
Stage1-vs-Stage3
1.114230E-01
Stage1-vs-Stage4
3.483400E-01
Stage2-vs-Stage3
1.325960E-01
Stage2-vs-Stage4
4.279200E-01
Stage3-vs-Stage4
1.466050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.520600E-01
Normal-vs-AfricanAmerican
7.896800E-01
Normal-vs-Asian
4.385200E-01
Caucasian-vs-AfricanAmerican
5.006600E-01
Caucasian-vs-Asian
9.211600E-01
AfricanAmerican-vs-Asian
5.088800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.346400E-01
Normal-vs-Female
6.368400E-01
Male-vs-Female
2.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.274000E-01
Normal-vs-Age(41-60Yrs)
7.658200E-01
Normal-vs-Age(61-80Yrs)
3.936400E-01
Normal-vs-Age(81-100Yrs)
2.209200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.202600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.697800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.744600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.054000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.521000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.158800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.829970E-01
Normal-vs-Daily Drinker
1.768790E-01
Normal-vs-Weekly Drinker
9.425800E-01
Normal-vs-Occasional Drinker
8.324000E-01
Normal-vs-Social Drinker
5.078200E-01
Non Drinker-vs-Daily Drinker
7.830600E-01
Non Drinker-vs-Weekly Drinker
2.696400E-01
Non Drinker-vs-Occasional Drinker
4.118200E-02
Non Drinker-vs-Social Drinker
2.285000E-01
Daily Drinker-vs-Weekly Drinker
2.301600E-01
Daily Drinker-vs-Occasional Drinker
3.950200E-02
Daily Drinker-vs-Social Drinker
1.872950E-01
Weekly Drinker-vs-Occasional Drinker
9.379400E-01
Weekly Drinker-vs-Social Drinker
6.214200E-01
Occasional Drinker-vs-Social Drinker
4.731600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.069000E-01
Normal-vs-Grade 2
2.549900E-02
Normal-vs-Grade 3
1.310150E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.733800E-02
Grade 1-vs-Grade 3
4.298200E-02
Grade 1-vs-Grade 4
1.069000E-01
Grade 2-vs-Grade 3
7.855400E-01
Grade 2-vs-Grade 4
2.549900E-02
Grade 3-vs-Grade 4
1.310150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.737000E-01
Normal-vs-NonDiabetic
4.077200E-01
Diabetic-vs-NonDiabetic
7.713000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.987200E-01
Normal-vs-NoPancreatitis
4.483200E-01
Pancreatitis-vs-NoPancreatitis
7.639600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.443800E-01
Normal-vs-N1
5.061400E-01
N0-vs-N1
8.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.793600E-01
Normal-vs-TP53-NonMutant
5.261200E-01
TP53-Mutant-vs-TP53-NonMutant
6.887500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
